| pubmed-article:19303575 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19303575 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19303575 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:19303575 | lifeskim:mentions | umls-concept:C0027051 | lld:lifeskim |
| pubmed-article:19303575 | lifeskim:mentions | umls-concept:C0136123 | lld:lifeskim |
| pubmed-article:19303575 | lifeskim:mentions | umls-concept:C0332152 | lld:lifeskim |
| pubmed-article:19303575 | lifeskim:mentions | umls-concept:C1524081 | lld:lifeskim |
| pubmed-article:19303575 | lifeskim:mentions | umls-concept:C0581603 | lld:lifeskim |
| pubmed-article:19303575 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:19303575 | lifeskim:mentions | umls-concept:C1515021 | lld:lifeskim |
| pubmed-article:19303575 | lifeskim:mentions | umls-concept:C0242751 | lld:lifeskim |
| pubmed-article:19303575 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19303575 | pubmed:dateCreated | 2009-3-23 | lld:pubmed |
| pubmed-article:19303575 | pubmed:abstractText | The European trial on Reduction Of cardiac events with Perindopril in patients with stable coronary Artery disease (EUROPA) demonstrated the benefits of perindopril with respect to secondary prevention of cardiovascular risk in patients with stable coronary artery disease. | lld:pubmed |
| pubmed-article:19303575 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19303575 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19303575 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19303575 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19303575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19303575 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19303575 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19303575 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19303575 | pubmed:issn | 1875-2136 | lld:pubmed |
| pubmed-article:19303575 | pubmed:author | pubmed-author:BertrandMiche... | lld:pubmed |
| pubmed-article:19303575 | pubmed:author | pubmed-author:SimoonsMaarte... | lld:pubmed |
| pubmed-article:19303575 | pubmed:author | pubmed-author:RemmeWillem... | lld:pubmed |
| pubmed-article:19303575 | pubmed:author | pubmed-author:FoxKim MKM | lld:pubmed |
| pubmed-article:19303575 | pubmed:author | pubmed-author:FerrariRobert... | lld:pubmed |
| pubmed-article:19303575 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19303575 | pubmed:volume | 102 | lld:pubmed |
| pubmed-article:19303575 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19303575 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19303575 | pubmed:pagination | 89-96 | lld:pubmed |
| pubmed-article:19303575 | pubmed:dateRevised | 2011-4-25 | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:meshHeading | pubmed-meshheading:19303575... | lld:pubmed |
| pubmed-article:19303575 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19303575 | pubmed:articleTitle | Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial. | lld:pubmed |
| pubmed-article:19303575 | pubmed:affiliation | Hôpital cardiologique, boulevard du Prof.-Leclercq, 59037 Lille, France. | lld:pubmed |
| pubmed-article:19303575 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19303575 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19303575 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19303575 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19303575 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19303575 | lld:pubmed |
